NCT03903302View on ClinicalTrials.gov

Study Investigation Pharmacokinetics and Pharmacodynamics of CS1

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 6, 2017

Primary Completion Date

February 28, 2018

Study Completion Date

March 27, 2018

Conditions
Thrombosis
Interventions
DRUG

CS1-Sodium Valproate

Single and multiple dose evaluation of CS1

Trial Locations (1)

75237

CTC Clinical Trial Consultants AB, Uppsala

Sponsors
All Listed Sponsors
lead

Cereno Scientific AB

INDUSTRY

NCT03903302 - Study Investigation Pharmacokinetics and Pharmacodynamics of CS1 | Biotech Hunter | Biotech Hunter